Chief Medical Director
CERC (Cardiovascular European Research Center)
Rotterdam, Zuid-Holland, Netherlands
Dr. Pieter Smits is an interventional cardiologist for more than 25 years and the former Director of the Interventional Cardiology Department of the Maasstad Hospital, Rotterdam, The Netherlands. Currently he is Chief Medical Director at Cardiovascular European Research Center (CERC) in Massy, France. He has been the principal investigator of multiple large scale randomized controlled DES trials like: COMPARE, COMPARE II, COMPARE-ACUTE, COMPARE-ABSORB, MASTER-DAPT and Chairman of COMPARE-CRUSH and COMPARE-STEMI. He has been very active in the field of bioresorbable scaffolds from the very beginning and an expierenced operator in complex and high risk coronary lesions.
Currently he is the PI of the multicenter trial COMPARE 60/80 HBR and the ongoing COMPARE-ABSORB with 7 years FU, the longest FU in a large scale RCT with ABSORB.
Disclosure information not submitted.
Live Case from St. Francis Hospital | Roslyn, NY
Saturday, March 8, 2025
8:32 AM – 9:25 AM ET
CLINICAL OUTCOMES: FFR, IFR, IMR, AND CFR RESULTS FROM CLINICAL TRIALS
Saturday, March 8, 2025
9:25 AM – 10:45 AM ET
Saturday, March 8, 2025
10:21 AM – 10:45 AM ET
Continuous Thermodilution Method for Diagnosing CMD
Saturday, March 8, 2025
11:33 AM – 11:41 AM ET
What Do the US and EU Guidelines Say (and Why)?
Saturday, March 8, 2025
4:45 PM – 4:55 PM ET
Live Case from Providence Swedish Heart and Vascular | Seattle, WA
Sunday, March 9, 2025
2:10 PM – 2:50 PM ET
Sunday, March 9, 2025
2:50 PM – 4:20 PM ET
Panel Discussion | Will Angio FFR Become the Dominant Test for Physiology?
Sunday, March 9, 2025
4:02 PM – 4:20 PM ET
5-year FU of the COMPARE-ABSORB Trial and Update on the Ongoing 7-Year FU
Monday, March 10, 2025
11:11 AM – 11:19 AM ET
Panel Discussion | Is There a Role/Need for Bioresorbable and/or Bioadaptor Platforms?
Monday, March 10, 2025
11:59 AM – 12:25 PM ET